Condition: Lung Cancer · Sponsor: Instituto Nacional de Cancerologia de Mexico
This prospective study aims to detect early-stage lung cancer using low-dose computed tomography (LDCT) in Mexicans aged 50 or older who are current or former heavy smokers, non-smokers exposed to significant wood smoke, or diagnosed with COPD. Annual LDCT, spirometry, and serum biomarker tests will be conducted over 3 years, and a follow-up lasting up to 10 years.
This description comes directly from the study's public registry record.
Oscar G Arrieta, M.D., M.Sc. · 5556280400 · ogarrieta@gmail.com
Marisol Arroyo Hernández, M.D. · 5556280400 · marisol.neumologia@gmail.com
Always discuss trial participation with your own doctor first.
| Instituto Nacional de Cancerologia (INCan) Mexico | Mexico City, Tlalpan, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06535451